Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) EPS (Weighted Average and Diluted) (2024 - 2025)

Connect Biopharma Holdings' EPS (Weighted Average and Diluted) history spans 2 years, with the latest figure at -$0.31 for Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) fell 34.78% year-over-year to -$0.31; the TTM value through Sep 2025 reached -$0.89, down 631.57%, while the annual FY2024 figure was -$0.28, 75.22% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q3 2025 was -$0.31 at Connect Biopharma Holdings, down from -$0.23 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.27 in Q2 2024 and bottomed at -$0.31 in Q3 2025.